Advances in artificial intelligence (AI) are happening at a much quicker pace than anyone could have predicted. This emerging technology is now being used by businesses and is even finding its way into consumer products. One industry that has fully embraced AI is healthcare and doctors and other hospital staff are using advanced machine learning algorithms to solve problems in new ways. TechRadar Pro spoke with HeartFlow's Founder and Chief Technology Officer Charles A. Taylor to learn more about how the company is using deep learning to build 3-D models of patients' hearts to provide doctors with a safer and more effective way of diagnosing cardiovascular disease. HeartFlow has pioneered technology to help clinicians diagnose coronary heart disease (CHD).
Information Age discusses how artificial intelligence is transforming the NHS, and its potential in other sectors too with Charles A. Taylor, founder and chief technology officer at HeartFlow. The potential for AI in healthcare is tremendous as it increasingly becomes integrated into the healthcare ecosystem. AI is transforming the way doctors deliver cost-effective, high-quality diagnostic and treatment services to their patients. For example, the technology can identify patterns and anomalies in diagnostic data from medical scans at a speed and volume that humans are simply unable to replicate. The processing power of AI has applications far beyond providing simple diagnoses.
WIRE)--New technology using deep learning and advanced algorithms to evaluate blood flow to the heart is now being used in English hospitals to fight against coronary heart disease. Coronary heart disease (CHD) is one of the leading causes of death in the UK. It is responsible for more than 66,000 deaths each year and it is estimated that 2.3 million people in the UK are currently living with the diseasei. CHD develops when the arteries leading to the heart narrow or become blocked, which can reduce blood flow, and cause chest pain and heart attacksii. The HeartFlow FFRct Analysis is being supported by NHS England as part of the Innovation and Technology Payment (ITP) programme to help physicians better diagnose coronary heart disease.
Coronary heart disease (CHD) is one of the leading causes of death in the UK; it's responsible for more than 66,000 deaths each year, and it's estimated that 2.3 million people in the UK are currently living with the disease. Imaging is an important part of diagnosing people and managing treatment with a range of cardiovascular diseases, and the NHS uses Echo, MRI and CT scans to do this. A CT scan is used to do a coronary CT angiography, which involves taking images of the heart blood vessels and using the CT scan with some dye contrast into the blood vessels. This enables doctors to see if blood vessels are narrowing, causing patients to have chest pain or angina. The test has been around for the last 10 or 15 years but has increased in usage as radiation doses have decreased dramatically.
Healthcare is a world of perverse incentives. One person's waste is another person's annual bonus. If you have shares in Novo Nordisk, you don't really want people to eat more fruits and vegetables, because then sales of diabetes meds might drop. The same is true on a larger scale for hospital systems that get paid to conduct tests and perform surgeries instead of keeping people healthy. It doesn't pay--yet--to keep people healthy.